Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation

被引:44
作者
Lewis, Benjamin C.
Mackenzie, Peter I.
Elliot, David J.
Burchell, Brian
Bhasker, C. Ramana
Miners, John O. [1 ]
机构
[1] Flinders Univ S Australia, Dept Clin Pharmacol, Adelaide, SA, Australia
[2] Flinders Med Ctr, Adelaide, SA, Australia
[3] Univ Dundee, Dept Biochem Med, Dundee DD1 4HN, Scotland
基金
英国医学研究理事会;
关键词
UDP-glucuronosyltransferase; glucuronidation; structure-function; autoactivation; UGT2B7; UGT2B15;
D O I
10.1016/j.bcp.2006.12.021
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Despite the important role of UDP-glucuronosyltransferases (UGT) in the metabolism of drugs, environmental chemicals and endogenous compounds, the structural features of these enzymes responsible for substrate binding and selectivity remain poorly understood. Since UGT2B7 and UGT2B15 exhibit distinct, but overlapping, substrate selectivities, UGT2B7-UGT2B15 chimeras were constructed here to identify substrate binding domains. A UGT2B7-15-7 chimera that incorporated amino acids 61-194 of UGT2B15 glucuronidated the UGT2B15 substrates testosterone and phenolphthalein, but not the UGT2B7 substrates zidovudine and 11 alpha-hydroxyprogesterone. Derived apparent K-m values for testosterone and phenolphthalein glucuronidation by UGT2B7-15((61-194))-7 were similar in magnitude to those determined for UGT2B15. Moreover, glucuronidation of the non-selective. substrate 4-methylumbelliferone (4MU) by UGT2B7-15((61-194))-7 and UGT2B15 followed Michaelis-Menten and weak substrate, inhibition kinetics, respectively, whereas 4MU glucuronidation by UGT2B7 exhibited sigmoidal kinetics characteristic of autoactivation. Six UGT2B7-15-7 chimeras that incorporated smaller domains of UGT2B15 were subsequently generated. Of these, UGT2B7-15((61-157))-7, UGT2B7-15((91-157))-7 and UGT2B7-15((61-91))-7 glucuronidated 4MU, but activity towards the other substrates investigated here was not detected. Like UGT2B7, the UGT2B7-15((61-157))-7, UGT2B7-15((91-157))-7 and UGT2B7-15((61-91))-7 chimeras exhibited sigmoidal 4MU glucuronidation kinetics. The sigmoidal 4MU kinetic data were well modelled using both the Hill equation and the expression for a two-site model that assumes the simultaneous binding of two substrate molecules at equivalent sites. it may be concluded that residues 61-194 of UGT2B15 are responsible for substrate binding and for conferring the unique substrate selectivity of UGT2B15, while residues 158-194 of UGT2B7 appear to facilitate the binding of multiple 4MU molecules within the active site. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1463 / 1473
页数:11
相关论文
共 35 条
[1]  
Barbier O, 2000, DRUG METAB DISPOS, V28, P497
[2]   UDP-glucuronosyltransferase 2B7 is the major enzyme responsible for gemcabene glucuronidation in human liver microsomes [J].
Bauman, JN ;
Goosen, TC ;
Tugnait, M ;
Peterkin, V ;
Hurst, SI ;
Menning, LC ;
Milad, M ;
Court, MH ;
Williams, JA .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (09) :1349-1354
[3]   Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers [J].
Chung, JY ;
Cho, JY ;
Yu, KS ;
Kim, JR ;
Jung, HR ;
Lim, KS ;
Jang, IJ ;
Shin, SG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (06) :486-494
[4]  
Coffman BL, 1998, DRUG METAB DISPOS, V26, P73
[5]   Opioids bind to the amino acids 84 to 118 of UDP-glucuronosyltransferase UGT2B7 [J].
Coffman, BL ;
Kearney, WR ;
Goldsmith, S ;
Knosp, BM ;
Tephly, TR .
MOLECULAR PHARMACOLOGY, 2003, 63 (02) :283-288
[6]   Analysis of opioid binding to UDP-glucuronosyltransferase 2B7 fusion proteins using nuclear magnetic resonance spectroscopy [J].
Coffman, BL ;
Kearney, WR ;
Green, MD ;
Lowery, RG ;
Tephly, TR .
MOLECULAR PHARMACOLOGY, 2001, 59 (06) :1464-1469
[7]   Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTS):: S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9 [J].
Court, MH ;
Duan, SX ;
Guillemette, C ;
Journault, K ;
Krishnaswamy, S ;
Von Moltke, LL ;
Greenblatt, DJ .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (11) :1257-1265
[8]   Alteration of human UDP-glucuronosyltransferase UGT2B17 regio-specificity by a single amino acid substitution [J].
Dubois, SG ;
Beaulieu, M ;
Lévesque, E ;
Hum, DW ;
Bélanger, A .
JOURNAL OF MOLECULAR BIOLOGY, 1999, 289 (01) :29-39
[9]   Homodimerization of human bilirubin-uridine-diphosphoglucuronate glucuronosyltransferase-1 (UGT1A1) and its functional implications [J].
Ghosh, SS ;
Sappal, BS ;
Kalpana, GV ;
Lee, SW ;
Chowdhury, JR ;
Chowdhury, NR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (45) :42108-42115
[10]  
GREEN MD, 1994, DRUG METAB DISPOS, V22, P799